OTLK smart money

Outlook Therapeutics, INC. (OTLK): 5 insider buys in the public filings.

Insider buys, 12 months$7.9M

Insider buys

FiledWhoRoleAmountPrice
2026-08-14Sukhtian Ghiath M.Director,TenPercentOwner$2.5M$0.99
2026-07-29Sukhtian Faisal GhiathDirector$100k$1.05
2026-06-01Gms Ventures & InvestmentsDirector,TenPercentOwner$5.0M$0.59
2026-05-27Hilzinger Kurt JDirector$176k$0.44
2026-05-27Sukhtian Faisal GhiathDirector$50k$0.41
Open the live smart money map